Search

Anti-synthetase Syndrome Complicated by Pyogenic Myositis

Journal: Current Medical Imaging
Volume: 18 Issue: 7 Year: 2022 Page: 776-779
Author(s): David Lizarazo,Karen Cifuentes,Paula Andrea Forero,Hernan Páez

The Haywain: Anti-synthetase Antibodies in Patients with Inflammatory Diseases: Targeting Monocytes or Neutrophils?

Journal: Current Medicinal Chemistry
Volume: 27 Issue: 1 Year: 2020 Page: 2863-2871
Author(s): Bob Meek,Ger T. Rijkers

Identification of Active Phytochemical from Traditional Herbal Knowledgebase Targeting Pantothenate Synthetase for Anti-tuberculosis Therapy

Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 0 Year: 2021 Page: 1-13
Author(s): Saurov Mahanta,Bhaskarjyoti Gogoi,Pankaj Chetia,Bhaben Tanti,Pratap Jyoti Handique

Computational Sampling and Simulation Based Assessment of Novel Mycobacterium tuberculosis Glutamine Synthetase Inhibitors: Study Involving Structure Based Drug Design and Free Energy Perturbation

Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 9 Year: 2016 Page: 978-995
Author(s): Priyanka Suryadevara,Perumal Yogeeswari,Vijay Soni,Parthiban Brindha Devi,Vinay Kumar Nandicoori,Dharmarajan Sriram

The Prokaryotic FAD Synthetase Family: A Potential Drug Target

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 2637-2648
Author(s): Ana Serrano, Patricia Ferreira, Marta Martinez-Julvez, Milagros Medina

Antitrypanosomal Activity & Docking Studies of Components of Crateva adansonii DC Leaves: Novel Multifunctional Scaffolds

Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 8 Year: 2014 Page: 981-990
Author(s): Ngozichukwuka Peace Igoli,Carol Jean Clements,Rajeev Kumar Singla,John Ogbaji Igoli,Nzekwe Uche,Alexander Irvine Gray

Cyclopentenyl Cytosine (CPEC): An Overview of its in vitro and in vivo Activity

Journal: Current Cancer Drug Targets
Volume: 7 Issue: 5 Year: 2007 Page: 504-509
Author(s): K.J.M. Schimmel, H. Gelderblom, H.J. Guchelaar

Journal: Current Medicinal Chemistry
Volume: 15 Issue: 2 Year: 2008 Page: 2760-2770
Author(s): B. Hegymegi-Barakonyi, R. Szekely, Z. Varga, R. Kiss, G. Borbely, G. Nemeth, P. Banhegyi, J. Pato, Z. Greff, Z. Horvath, G. Meszaros, J. Marosfalvi, D. Eros, C. Szantai-Kis, N. Breza, S. Garavaglia, S. Perozzi, M. Rizzi, D. Hafenbradl, M. Ko, Y. Av-Gay, B. M. Klebl, L. Orfi, G. Keri

Mesoionic Oxatriazoles (MOTA): NO-Donating Characteristics and Pharmacology

Journal: Current Pharmaceutical Design
Volume: 8 Issue: 3 Year: 2002 Page: 167-176
Author(s): R. J. Gryglewski, E. Marcinkiewicz, J. Robak, Z. Michalska, J. Madej

Neuroprotection in Huntington;s Disease

Journal: Letters in Drug Design & Discovery
Volume: 2 Issue: 2 Year: 2005 Page: 143-147
Author(s): Raphael M. Bonelli, Anna K. Hodl, Hans-Peter Kapfhammer